Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc. > Vivo Cannabis Reduces Outstanding Debentures From $27.1 Mill
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(105)
•••
Comment by Schaffhausenon Sep 18, 2020 10:04am
106 Views
Post# 31580528

RE:RE:RE:RE:Vivo Cannabis Reduces Outstanding Debentures From $27.1 Mill

RE:RE:RE:RE:Vivo Cannabis Reduces Outstanding Debentures From $27.1 Mill
The news is all spelled out. 60% SALES CAGR as per VIVO September presentation. Lowest EV versus revenue ratio of peers. Whats needed is a frypan across the head, not more good news. Cheers, Schaff
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities